This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mitra, D. Articles by Stillman, D. J. Search for Related Content PubMed PubMed Citation Articles by Mitra, D. Articles by Stillman, D. J.

SWI/SNF Binding to the HO Promoter Requires Histone Acetylation and Stimulates TATA-Binding Protein Recruitment

Doyel Mitra, Emily J. Parnell, Jack W. Landon, Yaxin Yu, and David J. Stillman^*

Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah 84132

Received 21 September 2005/ Returned for modification 4 November 2005/ Accepted 5 March 2006

We use chromatin immunoprecipitation assays to show that the Gcn5 histone acetyltransferase in SAGA is required for SWI/SNF association with the HO promoter and that binding of SWI/SNF and SAGA are interdependent. Previous results showed that SWI/SNF binding to HO was Gcn5 independent, but that work used a strain with a mutation in the Ash1 daughter-specific repressor of HO expression. Here, we show that Ash1 functions as a repressor that inhibits SWI/SNF binding and that Gcn5 is required to overcome Ash1 repression in mother cells to allow HO transcription. Thus, Gcn5 facilitates SWI/SNF binding by antagonizing Ash1. Similarly, a mutation in SIN3, like an ash1 mutation, allows both HO expression and SWI/SNF binding in the absence of Gcn5. Although Ash1 has recently been identified in a Sin3-Rpd3 complex, our genetic analysis shows that Ash1 and Sin3 have distinct functions in regulating HO. Analysis of mutant strains shows that SWI/SNF binding and HO expression are correlated and regulated by histone acetylation. The defect in HO expression caused by a mutant SWI/SNF with a Swi2(E834K) substitution can be partially suppressed by ash1 or spt3 mutation or by a gain-of-function V71E substitution in the TATA-binding protein (TBP). Spt3 inhibits TBP binding at HO, and genetic analysis suggests that Spt3 and TBP(V71E) act in the same pathway, distinct from that of Ash1. We have detected SWI/SNF binding at the HO TATA region, and our results suggest that SWI/SNF, either directly or indirectly, facilitates TBP binding at HO.

Present address: Department of Molecular Genetics, Albert Einstein College of Medicine, Bronx, NY 10461.

This article has been cited by other articles:

• Witcher, M., Pettersson, F., Dupere-Richer, D., Padovani, A., Summers-Deluca, L., Baldwin, A. S., Miller, W. H. Jr (2008). Retinoic acid modulates chromatin to potentiate tumor necrosis factor alpha signaling on the DIF2 promoter. Nucleic Acids Res 36: 435-443 [Abstract] [Full Text]  
• Biswas, D., Takahata, S., Xin, H., Dutta-Biswas, R., Yu, Y., Formosa, T., Stillman, D. J. (2008). A Role for Chd1 and Set2 in Negatively Regulating DNA Replication in Saccharomyces cerevisiae. Genetics 178: 649-659 [Abstract] [Full Text]  
• Laprade, L., Rose, D., Winston, F. (2007). Characterization of New Spt3 and TATA-Binding Protein Mutants of Saccharomyces cerevisiae: Spt3 TBP Allele-Specific Interactions and Bypass of Spt8. Genetics 177: 2007-2017 [Abstract] [Full Text]  
• Schwabish, M. A., Struhl, K. (2007). The Swi/Snf Complex Is Important for Histone Eviction during Transcriptional Activation and RNA Polymerase II Elongation In Vivo. Mol. Cell. Biol. 27: 6987-6995 [Abstract] [Full Text]  
• Chandy, M., Gutierrez, J. L., Prochasson, P., Workman, J. L. (2006). SWI/SNF Displaces SAGA-Acetylated Nucleosomes.. Eukaryot Cell 5: 1738-1747 [Abstract] [Full Text]